Interleukin-18 in hemophagocytic lymphohistiocytosis

Citation
H. Takada et al., Interleukin-18 in hemophagocytic lymphohistiocytosis, LEUK LYMPH, 42(1-2), 2001, pp. 21-28
Citations number
74
Categorie Soggetti
Hematology,"Onconogenesis & Cancer Research
Journal title
LEUKEMIA & LYMPHOMA
ISSN journal
10428194 → ACNP
Volume
42
Issue
1-2
Year of publication
2001
Pages
21 - 28
Database
ISI
SICI code
1042-8194(200106)42:1-2<21:IIHL>2.0.ZU;2-9
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is characterized by dysregulated h yperactivation of macrophages and T helper 1 (Th1) cells accompanied by exc essive secretion of inflammatory cytokines. Although TNF-alpha and IFN-gamm a are known to be important factors for the development of the disease, the mechanism of their overproduction has not been clarified, yet. We measured serum IL-18 levels of patients with HLH to investigate the possible signif icance of IL-18 in its pathophysiology, especially in IFN-gamma production. IL-18 levels were significantly increased in all patients with HLH compare d with healthy controls. A significant correlation was observed between IL- 18 and IFN-gamma levels. In addition to IFN-gamma and soluble Fas ligand (s FasL), IL-18 levels significantly correlated with disease activity. IL-18 m ay play important roles in the pathogenesis of HLH, particularly through in duction of Th1 cells. In addition, IL-18 measurement may not only be useful for the diagnosis, but also for the evaluation of disease activity.